NumerixS Investment Technologies’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

NumerixS Investment Technologies’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,300	Closed	-$31K	–	1390
2019 Q4	$31K	Sell	1,300 -967	-43%	-$26.7K	0.01%	890
2019 Q3	$61K	Buy	+2,267	New	+$63.6K	0.02%	686
2018 Q4	–	Sell	-7,900	Closed	-$212K	–	1514
2018 Q3	$212K	Buy	+7,900	New	+$258K	0.04%	569
2018 Q1	–	Sell	-3,400	Closed	-$166K	–	1371
2017 Q4	$166K	Buy	+3,400	New	+$172K	0.04%	514
2017 Q3	–	Sell	-27,590	Closed	-$1.55M	–	1428
2017 Q2	$1.55M	Buy	27,590 +16,190	+142%	+$648K	0.23%	99
2017 Q1	$447K	Sell	11,400 -13,100	-53%	-$417K	0.05%	455
2016 Q4	$550K	Buy	+24,500	New	+$479K	0.07%	355
2016 Q3	–	Sell	-9,900	Closed	-$234K	–	1378
2016 Q2	$234K	Sell	9,900 -12,500	-56%	-$309K	0.03%	657
2016 Q1	$457K	Buy	22,400 +15,000	+203%	+$476K	0.05%	494
2015 Q4	$381K	Buy	+7,400	New	+$359K	0.05%	511

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

NumerixS Investment Technologies's PTLA Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 1,300 shares — an estimated $31K sold.

NumerixS Investment Technologies first reported a position in PTLA in Q4 2015 and held it in 10 quarters. The position peaked at $1.55M in Q2 2017. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

NumerixS Investment Technologies reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 1,300 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $31K.
NumerixS Investment Technologies first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 10 quarters.
NumerixS Investment Technologies's Portola Pharmaceuticals, Inc. position peaked at $1.55M in Q2 2017.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.